Bimekizumab (Bimzelx®) | UCB
UCB's Global Corporate Website

Bimekizumab (Bimzelx®)

Disease area studied Abbreviated title Phase Study ID Registry database Study results Plain language summary Publication (if available)
Ankylosing Spondylitis Phase 2 AS0008
Completed
NCT02963506
2016-001102-42
LINK
LINK
van der Heijde D., Arthritis Rheumatol 2019; 71(Suppl 10), abs 0937
Ankylosing Spondylitis Phase 2 AS0009
Completed
NCT03355573
2017-001002-15
Nonradiographic Axial Spondyloarthritis Phase 3 AS0010
Ongoing
NCT03928704
2017-003064-13
Deodhar A., et al. Ann Rheum Dis 2022; 81(Suppl 1):772–3, abs POS0939
Ankylosing Spondylitis Phase 3 AS0011
Completed
NCT03928743
2017-003065-95
van der Heijde D., et al. Ann Rheum Dis 2022; 81(Suppl 1):12–3, abs OP0019
Ankylosing Spondylitis. Phase 2 AS0013
Completed
NCT03215277
2017-000957-37
LINK
Glatt S. et al., Ann Rheum Dis 2019; 78(8):1033-1040
Ankylosing Spondylitis and Nonradiographic Axial Spondyloarthritis Phase 3 AS0014
Ongoing
NCT04436640
2019-004163-47
Chronic Plaque Psoriasis Phase 3 DV0002
Completed
NCT03766685
Psoriatic Arthritis Phase 3 DV0004
Completed
NCT04109976
Chronic Plaque Psoriasis Phase 3 DV0006
Completed
2016-003427-30
Hidradenitis Suppurativa Phase 2 HS0001
Completed
NCT03248531
2017-000892-10
LINK
LINK
"Glatt S., Jemec G.B.E., Forman S., Sayed C., Schmieder G. et al. JAMA Dermatol 2021 [ePub] "
Hidradenitis Suppurativa Phase 3 HS0003
Ongoing
NCT04242446
2019-002550-23
Hidradenitis Suppurativa Phase 3 HS0004
Completed
NCT04242498
2019-002551-42
Hidradenitis Suppurativa Phase 3 HS0005
Ongoing
NCT04901195
2020-004179-42
Psoriatic Arthritis Phase 2 PA0008
Completed
NCT02969525
2016-001103-23
LINK
LINK
Ritchlin C.T. et al. The Lancet 2020; 395(10222):427–40
Psoriatic Arthritis Phase 2 PA0009
Completed
NCT03347110
2017-001003-74
LINK
Merola J., Behrens F., Kivitz A., Mease P., Mcinnes I. et al. Arthritis Rheumatol 2020; 72(S10):- 2020 Annual Meeting of the American College of Rheumatology (ACR) and 2020 Annual Meeting of the Association of Rheumatology Health Professionals (ARHP), November 05-09, 2020; ACR Convergence 2020 Virtual
Psoriatic Arthritis Phase 3 PA0010
Completed
NCT03895203
2017-002322-20
Psoriatic Arthritis Phase 3 PA0011
Completed
NCT03896581
2017-002804-29
Psoriatic Arthritis Phase 3 PA0012
Ongoing
NCT04009499
2018-004725-86
Chronic Plaque Psoriasis Phase 3 PS0008
Completed
NCT03412747
2016-003392-22
LINK
LINK
Warren R.B. et al. N Engl J Med 2021;385(2):130-41
Chronic Plaque Psoriasis Phase 3 PS0009
Completed
NCT03370133
2016-003425-42
LINK
LINK
Reich K. et al. Lancet 2021; 397(10273):487–98
Chronic Plaque Psoriasis Phase 2 PS0010
Completed
NCT02905006
2016-001891-31
LINK
LINK
Papp K.A., et al. J Am Acad Dermatol 2018; 79(2):277–286
Chronic Plaque Psoriasis Phase 2 PS0011
Completed
NCT03010527
2016-001892-57
LINK
LINK
Blauvelt, A. et al. Ann Rheum Dis 2019; 78 (Suppl. 2), s. 1834
Chronic Plaque Psoriasis Phase 3 PS0013
Completed
NCT03410992
2016-003426-16
LINK
Gordon K.B., Foley P., Krueger J.G., Pinter A., Reich K. et al. Lancet 2021; 397(10273):475–86
Chronic Plaque Psoriasis Phase 3 PS0014
Ongoing
NCT03598790
2016-003427-30
Chronic Plaque Psoriasis Phase 3 PS0015
Ongoing
NCT03536884
2017-003784-35
LINK
Chronic Plaque Psoriasis Phase 2 PS0016
Completed
NCT03025542
2016-002368-15
LINK
LINK
Oliver R., Krueger J.G., Glatt S., Vajjah P., Mistry C. et al. Br J Dermatol 2021 [ePub]
Chronic Plaque Psoriasis Phase 2 PS0018
Completed
NCT03230292
2016-002934-57
LINK
LINK
Gordon, K.B.; Langley, R.G.; Warren, R.B.; Okubo, Y.; Stein Gold, L.; Merola, J.F. et al. 2022 JAMA Dermatol (aheadofprint)
Plaque Psoriasis Phase 2 PS0020
Ongoing
NCT04718896
2020-001724-34
Moderate to Severe Plaque Psoriasis Phase 3 PS0032
Completed
NCT05020249
Rheumatoid Arthritis Phase 2 RA0123
Completed
NCT02430909
2014-003307-30
LINK
Glatt et al. Annals of the rheumatic diseases 2019 [ePub]
Ulcerative Colitis Phase 2 UC0011
Terminated
2016-000420-26 LINK